Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Incidence and risk factors of pulmonary hypertension after venous thromboembolism: An analysis of a large healthcare database

View ORCID ProfilePamela L. Lutsey, Kurt W. Prins, Line H. Evensen, Rob F. Walker, Joel F. Farley, Richard F. MacLehose, View ORCID ProfileAlvaro Alonso, Neil A. Zakai, Thenappan Thenappan
doi: https://doi.org/10.1101/2020.10.25.20219303
Pamela L. Lutsey
1Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pamela L. Lutsey
  • For correspondence: lutsey@umn.edu
Kurt W. Prins
3K.G. Jebsen - Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Line H. Evensen
2Division of Cardiovascular Sciences, School of Medicine, University of Minnesota, Minneapolis, Minnesota, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rob F. Walker
1Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel F. Farley
4Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard F. MacLehose
1Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alvaro Alonso
5Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alvaro Alonso
Neil A. Zakai
6Division of Hematology/Oncology; Department of Medicine & Department of Pathology and Laboratory Medicine; Larner College of Medicine at the University of Vermont, Burlington, Vermont, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thenappan Thenappan
2Division of Cardiovascular Sciences, School of Medicine, University of Minnesota, Minneapolis, Minnesota, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Pulmonary hypertension (PH) is a devastating potential complication of pulmonary embolism (PE), a manifestation of venous thromboembolism (VTE). The incidence of and risk factors for PH in those with prior VTE is poorly characterized.

Methods ICD codes from inpatient and outpatient medical claims from MarketScan administrative databases for years 2011-2018 were used were used to identify cases of VTE, comorbidities prior to the VTE event, and PH occurring subsequent to the VTE event. Cumulative incidence and hazard ratios (HR), and their 95% confidence intervals (CI), were calculated.

Results The 170,021 VTE cases included in the analysis were on average (± SD) 57.5 ± 15.8 years old and 50.5% were female. A total of 5,946 PH cases accrued over an average follow-up of 1.94 years. Two years after incident VTE the cumulative incidence (95% CI) of PH was 3.5% (3.4%, 3.7%) overall. It was higher among women [3.9% (3.8%-4.1%)] than men [3.2% (3.0%-3.3%)], and among patients presenting with PE [6.2% (6.0%-6.5%)] than those presenting with deep vein thrombosis-only [1.1% (1.0%-1.2%)]. Adjusting for age and sex, risk of PH was higher among VTE patients with underlying comorbidities. The strongest associations were observed with concomitant heart failure [HR: 2.17 (1.04-2.31)], chronic pulmonary disease [2.01 (1.90-2.14)], and myocardial infarction [1.53 (1.40-1.67)].

Conclusions In this large real-world population of insured people with VTE, 3.5% developed PH in the 2 years following their initial VTE event. Risk was higher among women, with increasing age, and in those with additional comorbidities at the time of the VTE event. These data provide insights into the burden of PH and risk factors for PH among VTE patients.

Competing Interest Statement

KWP served as a consultant for Actelion and receives grant funding from United Therapeutics. TT has served on an advisory board for Actelion and Gilead. All other authors report no competing interst.

Clinical Trial

N/A: This was secondary analysis of an existing administrative database

Funding Statement

Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R01-HL131579, as well as K24HL148521 (AA) and NIH K08 HL140100 (KWP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The University of Minnesota Institutional Review Board deemed this research exempt from review since it utilized administrative databases that were pre-existing, de-identified and HIPAA compliant.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The licensing agreements through which we are accessing the data prohibit us from sharing the data more broadly. However both datasets are available for purchase. Information about how to purchase the data is provided in the following links: - MarketScan: https://www.ibm.com/products/marketscan-research-databases/pricing - Medicare 20% sample: https://www.resdac.org/cms-fee-information-research-identifiable-data

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 27, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Incidence and risk factors of pulmonary hypertension after venous thromboembolism: An analysis of a large healthcare database
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Incidence and risk factors of pulmonary hypertension after venous thromboembolism: An analysis of a large healthcare database
Pamela L. Lutsey, Kurt W. Prins, Line H. Evensen, Rob F. Walker, Joel F. Farley, Richard F. MacLehose, Alvaro Alonso, Neil A. Zakai, Thenappan Thenappan
medRxiv 2020.10.25.20219303; doi: https://doi.org/10.1101/2020.10.25.20219303
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Incidence and risk factors of pulmonary hypertension after venous thromboembolism: An analysis of a large healthcare database
Pamela L. Lutsey, Kurt W. Prins, Line H. Evensen, Rob F. Walker, Joel F. Farley, Richard F. MacLehose, Alvaro Alonso, Neil A. Zakai, Thenappan Thenappan
medRxiv 2020.10.25.20219303; doi: https://doi.org/10.1101/2020.10.25.20219303

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (166)
  • Anesthesia (49)
  • Cardiovascular Medicine (448)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (188)
  • Epidemiology (5199)
  • Forensic Medicine (3)
  • Gastroenterology (193)
  • Genetic and Genomic Medicine (746)
  • Geriatric Medicine (76)
  • Health Economics (211)
  • Health Informatics (690)
  • Health Policy (350)
  • Health Systems and Quality Improvement (221)
  • Hematology (98)
  • HIV/AIDS (161)
  • Infectious Diseases (except HIV/AIDS) (5793)
  • Intensive Care and Critical Care Medicine (355)
  • Medical Education (101)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (754)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (230)
  • Oncology (473)
  • Ophthalmology (149)
  • Orthopedics (38)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (138)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (135)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (851)
  • Public and Global Health (1986)
  • Radiology and Imaging (342)
  • Rehabilitation Medicine and Physical Therapy (154)
  • Respiratory Medicine (282)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (74)
  • Surgery (107)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)